The annual per caput effective dose and the genetically significant dose to the Australian population, arising from the practice of nuclear medicine, were estimated from the results of a survey of all major hospitals.
The survey was conducted for a 4-wk time period during June-July 1991.
Patients were characterized by age and gender.
The use of diagnostic radiopharmaceuticals resulted in values of 64 muSv and 26 muSv per input for effective dose and the genetically significant dose, respectively.
The effective dose has shown a marked increase in the last decade.
These values may be compared to the estimated 2 mSv from natural background radiation.
Mots-clés Pascal : Diagnostic, Australie, Océanie, Enquête, Produit radioisotopique, Dose efficace, Dosimétrie, Hôpital
Mots-clés Pascal anglais : Diagnosis, Australia, Oceania, Inquiry, Radiopharmaceuticals, Effective dose, Dosimetry, Hospital
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0447262
Code Inist : 002A08F05. Création : 199406.